Form 4: Roivant Sciences Director Ilan Oren Reports Changes in Beneficial Ownership

Director Ilan Oren reports acquisition and disposal of Roivant Sciences Ltd. common shares related to director compensation and tax obligations.

Summary

• On July 23, 2024, Ilan Oren, a director of Roivant Sciences Ltd., reported changes in beneficial ownership of the company's common shares.
• Oren acquired 2,440 common shares as part of the company's Non-Employee Director Compensation Plan, which were fully vested on the grant date.
• Additionally, 215 common shares were disposed of to cover tax withholding obligations related to the vesting and settlement of previously granted shares at a price of $11.01.
• Following these transactions, Oren's direct ownership stands at 82,634 common shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as the transactions reflect standard compensation practices and compliance with regulations. There are no indications of negative events or concerns.

Positives

• The acquisition of shares reflects ongoing director compensation, aligning director interests with shareholder value.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they relate to director compensation and tax obligations.

Key Dates